Stemi Anterolateral

download Stemi Anterolateral

of 37

Transcript of Stemi Anterolateral

  • 7/30/2019 Stemi Anterolateral

    1/37

    Anterolateral wall ST ElevationMyocard Infarction (STEMI) , ONSET>12 H ,KILLIP II

    BY:Muh. Kemal Putra

    C 111 07 096

    SUPERVISOR:

    Dr. Khalid Saleh, Sp.Pd

    DIBAWAKAN DALAM RANGKA TUGAS KEPANITERAAN KLINIK

    BAGIAN KARDIOLOGY

    FAKULTAS KEDOKTERAN

    UNIVERSITAS HASANUDDIN

    MAKASSAR

    2012

    CASE PRESENTATION

  • 7/30/2019 Stemi Anterolateral

    2/37

    PATIENT IDENTITY

    Name : Mr. N

    Gender : Male

    Age : 52 years old

    Address : Sidrap

    Registration no. : 554712

    Date of admission : 19th June 2012

  • 7/30/2019 Stemi Anterolateral

    3/37

    ANAMNESIS

    Chief complain : Chest pain

    History of present illness :

    His chest pain begin + 1 day prior to admission at Wahidin

    Sudirohusodo hospital. The pain is felt at the substernal area,

    with continuous, stabbing sensation spreading to the back

    accompanied with cold sweat. Pain does not subside with rest.

  • 7/30/2019 Stemi Anterolateral

    4/37

    ANAMNESIS

    Nausea ( - ), vomiting ( - )

    Cough ( - ), Shortness of breath ( - ), Palpitation ( - )

    Dizziness ( - ), Headache ( - ) , Fever ( - )

    Urination = normal

    Defecation = normal

  • 7/30/2019 Stemi Anterolateral

    5/37

    ANAMNESIS

    HISTORY OF PREVIOUS ILLNESS

    History of heart disease ( - )

    History of hypertension is ( - )

    History of diabetes melitus ( - )

    History of dyslipidemia is unknown

    History of smoking ( - )

  • 7/30/2019 Stemi Anterolateral

    6/37

    PHYSICAL EXAMINATION

    General appearance : Moderate illness/well nourished/

    composmentis

    Vital Signs:

    BP : 110/70 mmHg RR : 26 x/min

    HR : 76x/min T : 36,8 (afebris)

    Head :Anemia ( - ) , Icterus ( - )

    Neck : JVP R+2cm H20

  • 7/30/2019 Stemi Anterolateral

    7/37

    PHYSICAL EXAMINATION

    Lung : Bronchovesicular, Rhonchi +/+ basal , Wheezing -/-

    Cor : I : Ictus cordis not visible

    P : Ictus cordis not palpable

    P : Dull, normal heart size

    -Upper border : left 2nd ICS

    -Right border : right parasternalis line

    -Left border : left medioclavicular line

    A : Heart Sound I/II pure regular, murmur(-)

  • 7/30/2019 Stemi Anterolateral

    8/37

    PHYSICAL EXAMINATION

    Abdomen :

    Inspection : flat and following breath movement

    Auscultation : peristaltic sound (+) , normal

    Palpation : liver and spleen unpalpable

    Percussion : tympani, ascites (-)

    Extremities : Edema -/-

  • 7/30/2019 Stemi Anterolateral

    9/37

    ECG FINDINGS

  • 7/30/2019 Stemi Anterolateral

    10/37

    ECG INTERPRETATION

    Sinus Rhythm

    QRS Rate : 90 x/minutes

    P Wave : 0.08

    PR interval : 0.16

    QRS complex : 0.08

    Axis : +65

    ST segment : ST elevation V3-V5, I, aVL,

  • 7/30/2019 Stemi Anterolateral

    11/37

    Rhythm Sinus

    Heart rate 90 x/ minute

    Anterolateral Myocardial Infarction

    ECG CONCLUSION

  • 7/30/2019 Stemi Anterolateral

    12/37

    ECHOCARDIOGRAPHY

  • 7/30/2019 Stemi Anterolateral

    13/37

    ECHOCARDIOGRAPHY

    CONCLUSION :

    LV systolic & dystolic dysfunction, EF 46%

    Dilated LA, LVH (+)

    MV prolaps

    Hypokinetic inferolateral septal

    PH-TR severe

  • 7/30/2019 Stemi Anterolateral

    14/37

    CHEST X-RAY

    CONCLUSION :

    Cardiomegaly and pulmonary edema

  • 7/30/2019 Stemi Anterolateral

    15/37

    Complete blood count

    WBC :17.93x103/ul

    RBC : 5.95X10^6/ul

    HGB : 16.6 gr/dl

    HCT : 51.9%

    PLT : 271 x 103/l

    Enzymes

    CK : 4118 U/L

    CK-MB : 319 U/L

    Trop T : >2.0

    Blood chemistry

    Blood glucose :138

    Ureum : 26 mg/dl

    Creatinine : 1.0 mg/dl

    SGOT : 407 u/dl

    SGPT : 87 u/ dl

    Total Cholesterol : 236 u/dl

    HDL : 137 u/dl

    LDL : 44 u/dl

    Trigliseride : 209 u/dl

    LABORATORIUM FINDINGS

  • 7/30/2019 Stemi Anterolateral

    16/37

    DIAGNOSIS

    Anterolateral wall STEMI onset >12 hours, Killip II

  • 7/30/2019 Stemi Anterolateral

    17/37

    INITIAL MANAGEMENT

    Bed rest

    O2 2-4 lpm ( via nasal canule )

    IVFD NaCl 0,9% 10 dpm

    Cedocard 10mg/ min/iv/SP

    Amiodarone 600mg/24 hrs/SP

    Arixtra 2,5mg/24hrs/SC

    Fargoxin 0,5mg/iv/bolus(slowly)

    CPG 75 mg 0-1-0/ oral

    Aspilet 80 mg 1-0-0/oral

    Captopril 6.25mg 1-1-1

    Simvastatin 20mg 0-0-1

    Alprazolam 0.5mg 0-0-1/ oral

    Laxadyne syr 0-0-2tbsp / oral

  • 7/30/2019 Stemi Anterolateral

    18/37

    ADVISE

    Coronary Angiography

  • 7/30/2019 Stemi Anterolateral

    19/37

    DISCUSSION

  • 7/30/2019 Stemi Anterolateral

    20/37

    DEFINITION

    Myocardial infarction (MI) rapid

    development of myocardial necrosis

    caused by a critical imbalance

    between the oxygen supply anddemand of the myocardium.

    This usually results from plaquerupture with thrombus formation in

    a coronary vessels, resulting in an

    acute reduction of blood supply to a

    portion of the myocardium.

  • 7/30/2019 Stemi Anterolateral

    21/37

    PaTHOPHYSIOLOGY

    Occurs when coronaryblood flow decreasesabruptly after athrombotic occlusion of

    a coronary arterypreviously affected byatherosclerosis.

    In most cases,infarction occurs whenan atheroscleroticplaque fissures,ruptures, or ulcerates.

  • 7/30/2019 Stemi Anterolateral

    22/37

    CLASSIFICATION

    ACS describe a group of conditions resulting from acute myocardial

    ischemia (insufficient blood flow to heart muscle) ranging from

    unstable angina to myocardial infarction.

  • 7/30/2019 Stemi Anterolateral

    23/37

    Gender and Age

    Men, increased risk after age 45

    Women, increased risk after age

    55

    Family History

    Heart disease diagnosed before

    age 55 in father or brother

    Heart disease diagnosed before

    age 65 in mother or sister

    Risk factors

    Non- Modifiable Modifiable

    Smoking

    Hypertension

    Diabetis Mellitus

    Dyslipidemia

    Obesity

    Lack of physical activity

  • 7/30/2019 Stemi Anterolateral

    24/37

    WHO DIAGNOSTIC CRITERIA

    1. Clinical history of ischaemic type chest pain lasting

    >20 minutes

    2. Changes in serial ECG tracings

    3. Rise of serum cardiac biomarkers such as

    creatinine kinase-MB fraction and troponin-T

  • 7/30/2019 Stemi Anterolateral

    25/37

    CLINICAL FEATURES

    Chest pain, >30 minutes

    Usually tight, crushing, and band

    likeLocation in retrosternal

    May radiate to left arm, throat, and

    jawAssociated features includingpalpitation, sweating,

    breathlessness, and nausea.

  • 7/30/2019 Stemi Anterolateral

    26/37

    ECS CHANGES IN AMI

    ST segment elevation

    over area of damage

    ST depression in leadsopposite infarction

    Pathological Q waves

    Reduced R waves

    Inverted T waves

    w v

  • 7/30/2019 Stemi Anterolateral

    27/37

    Leads with st elevation in

    mi

  • 7/30/2019 Stemi Anterolateral

    28/37

    Cardiac biomarkers

  • 7/30/2019 Stemi Anterolateral

    29/37

    DIAGNOSIS

    No

    Yes

    YesNo

    Acute Myocardial Infarction

    ( Q-wave, non-Q wave )

    NSTEMI( No ST-Segment

    ElevationMyocardial Infarction )

    Unstable Angina

    Signs of myocardial

    ischemia

    ST segmen elevation ?

    Biochemical cardiac markers ?

    Diagnose

    ECG

    Lab

  • 7/30/2019 Stemi Anterolateral

    30/37

    Manage chest pain and bad feeling/stress

    Oxygen 4 lpm ( increase the supply of oxygen)

    Give nitrat oral/IV (for the angina)

    Give antiplatelet

    Give morphine or petidine (for infark pain)

    Give diazepam 2/5mg (for make the patient relax)

    Therapy

  • 7/30/2019 Stemi Anterolateral

    31/37

    Hemodanamic stabilization

    Fasting first 8 hours after attack then eat soft food

    Give laxadyn

    Bed rest until 24 hours free from angina

    Blood pressure and heart rate is control with

    -Beta blocker

    -Ace inhibitor

    Therapy

  • 7/30/2019 Stemi Anterolateral

    32/37

    Myocardiac reprofusion as soon as possible

    Thrombolitic - streptokinase and t-PA

    Plaque stabilization

    Simvastatin

    Therapy

  • 7/30/2019 Stemi Anterolateral

    33/37

    PROGNOSIS

    Class Description Mortality Rate (%)

    I No clinical signs of heart failure 6

    II Rales or crackles in the lungs, an S3, and

    elevated jugular venous pressure

    17

    III Acute pulmonary edema 30 - 40

    IV Cardiogenic shock or hypotension

    (systolic BP < 90 mmHg), and evidence

    of peripheral vasoconstriction

    60 80

    KILLIP CLASSIFICATION

  • 7/30/2019 Stemi Anterolateral

    34/37

    COMPLICATION

    Congestive heart failure

    Myocardial rupture

    Arrhythmia

    Pericarditis

    Cardiogenic shock

  • 7/30/2019 Stemi Anterolateral

    35/37

    RISK SCORE FOR ACS

    TIMI Risk Score for STEMIHistorical

    Age 65-74

    >/= 75

    2 points

    3 points

    DM/HTN or Angina 1 point

    Exam

    SBP < 100 3 pointsHR > 100 2 points

    Killip II-IV 2 points

    Weight < 67 kg 1 point

    Presentation

    Anterior STE or

    LBBB

    1 point

    Time to rx > 4 hrs 1 point

    Risk Score = Total (0-14)

    Risk Score Odds of death by

    30D*

    0 0.1 (0.1-0.2)

    1 0.3 (0.2-0.3)

    2 0.4 (0.3-0.5)

    3 0.7 (0.6-0.9)

    4 1.2 (1.0-1.5)

    5 2.2 (1.9-2.6)

    6 3.0 (2.5-3.6)

    7 4.8 (3.8-6.1)

    8 5.8 (4.2-7.8)

    >8 8.8 (6.3-12)

    * referenced to average mortality (95%

    confidence intervals)

  • 7/30/2019 Stemi Anterolateral

    36/37

    RISK SCORE FOR ACSTIMI RISK SCORE FOR NSTEMI/UA

    Historical

    Age 65 years

    Presence of at least three risk

    factors for CAD

    Known coronary stenosis of 50 % Use of aspirin in past seven days

    Presentation

    Recent ( 0.5mm

    Calculated

    TIMI RiskScore

    Risk of >1

    Primary EndPoint* in

  • 7/30/2019 Stemi Anterolateral

    37/37